| $385M | ||
| $350M | ||
| $215M | ||
| $82M | ||
| $76M | ||
| $62M |
Buys | $2,997,466 | 17 | 100 |
Sells | $0 | 0 | 0 |
| Shenouda Maged | Chief Financial Officer | 5 | $1.25M | 0 | $0 | $1.25M |
| TRAVERSA SERGIO | Chief Executive Officer | 8 | $1.07M | 0 | $0 | $1.07M |
| Ence Chuck | CA and CO | 2 | $402,530 | 0 | $0 | $402,530 |
| Kelly Paul Edward | Chief Operating Officer | 2 | $284,060 | 0 | $0 | $284,060 |
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder in adults. The company was founded in 2004 and is headquartered in Coral Gables, Florida.
Over the last 12 months, insiders at Relmada Therapeutics, Inc. have bought $3M and sold $0 worth of Relmada Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Relmada Therapeutics, Inc. have bought $1.11M and sold $987,480 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Shenouda Maged (Chief Financial Officer) — $1.25M. TRAVERSA SERGIO (Chief Executive Officer) — $1.07M. Ence Chuck (CA and CO) — $402,530.
The last purchase of 27,500 shares for transaction amount of $113,300 was made by TRAVERSA SERGIO (Chief Executive Officer) on 2025‑12‑15.
| 2025-12-15 | TRAVERSA SERGIO | Chief Executive Officer | 27,500 0.0355% | $4.12 | $113,300 | -5.73% | ||
| 2025-12-15 | Shenouda Maged | Chief Financial Officer | 11,665 0.015% | $4.12 | $48,060 | -5.73% | ||
| 2025-11-05 | TRAVERSA SERGIO | Chief Executive Officer | 272,500 0.7992% | $2.20 | $599,500 | +64.73% | ||
| 2025-11-05 | Shenouda Maged | Chief Financial Officer | 500,000 1.4664% | $2.20 | $1.1M | +64.73% | ||
| 2025-11-05 | Kelly Paul Edward | Chief Operating Officer | 90,000 0.264% | $2.20 | $198,000 | +64.73% | ||
| 2025-11-05 | Ence Chuck | CAO and COO | 136,000 0.3989% | $2.20 | $299,200 | +64.73% | ||
| 2025-08-28 | TRAVERSA SERGIO | Chief Executive Officer | 55,976 0.161% | $0.74 | $41,422 | +398.74% | ||
| 2025-08-27 | TRAVERSA SERGIO | Chief Executive Officer | 129,455 0.3903% | $0.67 | $86,735 | +475.13% | ||
| 2025-08-26 | TRAVERSA SERGIO | Chief Executive Officer | 80,545 0.24% | $0.62 | $49,938 | +481.76% | ||
| 2025-05-20 | TRAVERSA SERGIO | Chief Executive Officer | 147,686 0.4151% | $0.56 | $82,246 | +251.76% | ||
| 2025-05-20 | Shenouda Maged | Chief Financial Officer | 60,000 0.1586% | $0.52 | $31,422 | +251.76% | ||
| 2025-05-19 | TRAVERSA SERGIO | Chief Executive Officer | 30,000 0.0888% | $0.50 | $14,994 | +310.61% | ||
| 2025-05-19 | Shenouda Maged | Chief Financial Officer | 90,000 0.2586% | $0.49 | $43,686 | +310.61% | ||
| 2025-05-16 | TRAVERSA SERGIO | Chief Executive Officer | 172,314 0.5063% | $0.45 | $77,472 | +351.19% | ||
| 2025-05-16 | Kelly Paul Edward | Chief Operating Officer | 200,000 0.5624% | $0.43 | $86,060 | +351.19% | ||
| 2025-05-16 | Ence Chuck | CA and CO | 228,961 0.6753% | $0.45 | $103,330 | +351.19% | ||
| 2025-05-16 | Shenouda Maged | Chief Financial Officer | 50,000 0.1444% | $0.44 | $22,100 | +351.19% | ||
| 2024-09-11 | TRAVERSA SERGIO | Chief Executive Officer | 51,407 0.1813% | $2.99 | $153,707 | -19.99% | ||
| 2024-09-11 | Shenouda Maged | Chief Financial Officer | 24,120 0.0839% | $2.95 | $71,154 | -19.99% | ||
| 2024-09-10 | TRAVERSA SERGIO | Chief Executive Officer | 33,014 0.1071% | $2.75 | $90,789 | -14.01% |
| TRAVERSA SERGIO | Chief Executive Officer | 1300000 1.7727% | $5.79M | 17 | 14 | <0.0001% |
| Shenouda Maged | Chief Financial Officer | 800000 1.0909% | $3.56M | 14 | 14 | <0.0001% |
| Kelly Paul Edward | Chief Operating Officer | 502295 0.6849% | $2.24M | 8 | 11 | +49.16% |
| Ence Chuck | CAO and COO | 403931 0.5508% | $1.8M | 5 | 0 | <0.0001% |
| SETH SANDESH | director | 123258 0.1681% | $548,498.10 | 2 | 0 | |
| CASAMENTO CHARLES J | director | 13000 0.0177% | $57,850.00 | 2 | 15 | <0.0001% |
| O'Gorman Cedric | Chief Medical Officer | 10121 0.0138% | $45,038.45 | 1 | 0 | +0.32% |
| Agharkar Shreeram | director | 5759 0.0079% | $25,627.55 | 2 | 0 |
$26,922,905 | 100 | 5.55% | $297.62M | |
$5,960,789 | 91 | -7.17% | $319.9M | |
$69,151,774 | 71 | 24.96% | $321.71M | |
$24,384,691 | 42 | -30.27% | $312.43M | |
$16,169,789 | 40 | 7.44% | $332.61M | |
$64,487,106 | 32 | -22.92% | $311.97M | |
$54,828,550 | 26 | -13.88% | $340.21M | |
Relmada Therapeutics, Inc. (RLMD) | $1,842,003 | 22 | -0.74% | $326.33M |
$65,355,913 | 13 | -3.42% | $355.62M | |
$10,143,329 | 12 | 11.84% | $314.35M | |
$81,667,942 | 12 | -57.54% | $357.88M | |
$112,952,085 | 11 | -19.19% | $360.3M | |
$13,043,783 | 8 | 732.82% | $305.16M | |
$603,645 | 8 | 57.40% | $360.27M | |
$1,346,998 | 7 | 25.06% | $297.64M | |
$17,675,244 | 7 | 92.20% | $307.8M | |
$2,720,023 | 3 | -11.76% | $343.41M | |
$4,888,000 | 3 | -20.50% | $338.6M | |
$20,020,000 | 1 | -75.24% | $354.71M |
| Increased Positions | 57 | +183.87% | 43M | +560.67% |
| Decreased Positions | 9 | -29.03% | 217,832 | -2.81% |
| New Positions | 35 | New | 34M | New |
| Sold Out Positions | <1 | Sold Out | 1,581 | Sold Out |
| Total Postitions | 79 | +154.84% | 51M | +557.86% |
| Ikarian Capital, Llc | $8,054.00 | 2.53% | 1.84M | +2M | +4,476.76% | 2025-09-30 |
| Driehaus Capital Management Llc | $3,234.00 | 1.01% | 740,006 | 0 | 0% | 2025-09-30 |
| Boothbay Fund Management, Llc | $3,029.00 | 0.95% | 693,236 | +693,236 | New | 2025-09-30 |
| Acadian Asset Management Llc | $2,546.00 | 0.8% | 582,543 | -36,936 | -5.96% | 2025-09-30 |
| Blackrock, Inc. | $2,220.00 | 0.7% | 508,000 | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $1,829.00 | 0.57% | 418,580 | +54,503 | +14.97% | 2025-09-30 |
| Advisorshares Investments Llc | $1,763.00 | 0.55% | 403,488 | +6,974 | +1.76% | 2025-09-30 |
| Geode Capital Management, Llc | $1,294.00 | 0.41% | 296,215 | -6,139 | -2.03% | 2025-09-30 |
| Marshall Wace, Llp | $1,189.00 | 0.37% | 272,053 | +117,485 | +76.01% | 2025-09-30 |
| Deutsche Bank Ag | $983.00 | 0.31% | 224,846 | 0 | 0% | 2025-09-30 |